A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This study will assess the safety, tolerability and glucose-lowering efficacy of MK-0893 in participants with type 2 diabetes mellitus. The primary hypothesis is that MK-0893 will reduce 24-hour weighted mean glucose (WMG) significantly more than placebo.
Epistemonikos ID: b2763c7be37eaf32755a2e783c109863acd3b1f0
First added on: May 11, 2024